RYVERNA
DEAD

Serial Number

87567242

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Aug 14, 2017

Add to watchlist:

No watchlists yet
View on USPTO

RYVERNA Trademark

Serial Number: 87567242

RYVERNA is a trademark filed by NOVARTIS AG on August 14, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

August 14, 2017

Registration Date

Not Registered

Published for Opposition

November 14, 2017

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 12, 2019 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 12, 2019 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 9, 2019 EXRA
SOU EXTENSION 2 GRANTED
Jan 7, 2019 EX2G
SOU EXTENSION 2 FILED
Jan 7, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 7, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 7, 2018 EXRA
SOU EXTENSION 1 GRANTED
Jul 5, 2018 EX1G
SOU EXTENSION 1 FILED
Jul 5, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 5, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 9, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 14, 2017 NPUB
PUBLISHED FOR OPPOSITION
Nov 14, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 25, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 30, 2017 CNSA
ASSIGNED TO EXAMINER
Sep 29, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 18, 2017 NWOS
NEW APPLICATION ENTERED
Aug 17, 2017 NWAP